Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV

ClinicalTrials.gov ID: NCT00001049

Public ClinicalTrials.gov record NCT00001049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 2:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Evaluation of the Safety and Toxicity of Zidovudine and Didanosine in Combination in HIV-Infected or Exposed Infants and a Phase II Study of the Effect of Didanosine vs. Combination Therapy With Zidovudine and Didanosine on HIV-1 RNA in Infants With HIV Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To determine the pharmacokinetics, safety, and efficacy of didanosine (ddI) alone or in combination with zidovudine (AZT) in HIV-infected infants. PER AMENDMENT 4/8/97: Part A study objectives are completed. Part B objectives: To assess the safety, toxicity, and tolerability and to compare anti-HIV activity, as measured by change in log10 RNA, of the two study arms. Early treatment of HIV-infected infants with antiretroviral agents may prevent the early and rapid decline of CD4 count and immunologic function. Combination therapy may be preferred over monotherapy, since resistance to a single agent can develop rapidly. Currently, there is little information on ddI monotherapy in young infants less than 90 days and no information on the use of combination therapy in this population.

Study identification

NCT ID
NCT00001049
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Enrollment
180 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
1 Day to 3 Months
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
May 31, 1998
Last update posted
Oct 31, 2021

Ends 1998

United States locations

U.S. sites
45
U.S. states
17
U.S. cities
32
Facility City State ZIP Site status
Univ of Alabama at Birmingham Schl of Med / Pediatrics Birmingham Alabama 35294
UCSD Med Ctr / Pediatrics / Clinical Sciences La Jolla California 920930672
Long Beach Memorial (Pediatric) Long Beach California 90801
Los Angeles County - USC Med Ctr Los Angeles California 90033
Harbor - UCLA Med Ctr / UCLA School of Medicine Los Angeles California 905022004
Children's Hosp of Oakland Oakland California 946091809
San Francisco Gen Hosp San Francisco California 94110
UCSF / Moffitt Hosp - Pediatric San Francisco California 941430105
Children's Hosp of Denver Denver Colorado 802181088
Univ of Connecticut / Farmington Farmington Connecticut 06032
Children's Hosp of Washington DC Washington D.C. District of Columbia 200102916
Howard Univ Hosp Washington D.C. District of Columbia 20060
North Broward Hosp District Fort Lauderdale Florida 33311
Univ of Florida Health Science Ctr / Pediatrics Jacksonville Florida 32209
Univ of Miami (Pediatric) Miami Florida 33161
Palm Beach County Health Dept Riviera Beach Florida 33404
Cook County Hosp Chicago Illinois 60612
Univ of Illinois College of Medicine / Pediatrics Chicago Illinois 60612
Chicago Children's Memorial Hosp Chicago Illinois 606143394
Univ of Chicago Children's Hosp Chicago Illinois 606371470
Tulane Univ / Charity Hosp of New Orleans New Orleans Louisiana 701122699
Univ of Maryland at Baltimore / Univ Med Ctr Baltimore Maryland 21201
Children's Hosp of Boston Boston Massachusetts 021155724
Baystate Med Ctr of Springfield Springfield Massachusetts 01199
Univ of Massachusetts Med School Worcester Massachusetts 016550001
Children's Hosp of Michigan Detroit Michigan 48201
Univ of Medicine & Dentistry of New Jersey / Univ Hosp Newark New Jersey 071032714
Saint Joseph's Hosp and Med Ctr/UMDNJ - New Jersey Med Schl Newark New Jersey 07103
Children's Hosp of New Jersey / UMDNJ - New Jersey Med Schl Newark New Jersey 071072198
Children's Hosp at Albany Med Ctr Albany New York 12208
Schneider Children's Hosp New Hyde Park New York 11040
Metropolitan Hosp Ctr New York New York 10029
Mount Sinai Med Ctr / Pediatrics New York New York 10029
Columbia Presbyterian Med Ctr New York New York 10032
Incarnation Children's Ctr / Columbia Presbyterian Med Ctr New York New York 10032
Harlem Hosp Ctr New York New York 10037
Univ of Rochester Medical Center Rochester New York 14642
SUNY Health Sciences Ctr at Syracuse / Pediatrics Syracuse New York 13210
Bronx Lebanon Hosp Ctr The Bronx New York 10457
Duke Univ Med Ctr Durham North Carolina 277103499
Children's Hosp of Philadelphia Philadelphia Pennsylvania 191044318
Saint Christopher's Hosp for Children Philadelphia Pennsylvania 191341095
Med Univ of South Carolina Charleston South Carolina 294253312
Children's Hosp of the King's Daughters Norfolk Virginia 23507
Med College of Virginia Richmond Virginia 23219

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00001049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 31, 2021 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00001049 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →